Evidence map›Paper›PMID 16611053›Full record

ReviewCurrent HIV research2006

Retrovirus translation initiation: Issues and hypotheses derived from study of HIV-1.

Alper Yilmaz, Cheryl Bolinger, Kathleen Boris-Lawrie

Open access · bronzeAbstract readReview
In one paragraph

Review in Current HIV research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alper YilmazCenter for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA.
Cheryl Bolinger
Kathleen Boris-Lawrie
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Role of Inflammation in Tax-mediated TumorigenesisP01CA100730 · NCI · WASHINGTON UNIVERSITY · PI Malachi Griffith · 2003 to 2026
$44.8M
Translational Control of Retroviral Unspliced mRNAR01CA108882 · NCI · OHIO STATE UNIVERSITY · PI BORIS-LAWRIE, KATHLEEN A. · 2006 to 2010
$976k
HIV STRUCTURAL GENE VECTORS--LIVE-ATTENUATED HIV VACCINER21AI046325 · NIAID · OHIO STATE UNIVERSITY · PI BORIS-LAWRIE, KATHLEEN A · 1999 to 2000
$219k
NCI NIH HHS P01 CA100730NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA16058NCI NIH HHS R01 CA108882NIAID NIH HHS R21 AI046325
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) has a small, multifunctional genome that encodes a relatively large and complex proteome. The virus has adopted specialized post-transcriptional control mechanisms to maximize its coding capacity while economically maintaining the information stored in cis-acting replication sequences. The conserved features of the 5' untranslated region of all viral transcripts suggest they are poor substrates for cap-dependent ribosome scanning and provide a compelling rationale for internal initiation of translation. This article summarizes key experimental results of studies that have evaluated HIV-1 translation initiation. A model is discussed in which cap-dependent and cap-independent initiation mechanisms of HIV-1 co-exist to ensure viral protein production in the context of 1) structured replication motifs that inhibit ribosome scanning, and 2) alterations in host translation machinery in response to HIV-1 infection or other cellular stresses. We discuss key issues that remain to be understood and suggest parameters to validate internal initiation activity in HIV-1 and other retroviruses.

Indexed as

HIV-1HumansPeptide Chain Initiation, TranslationalProtein BiosynthesisRNA, MessengerRNA, ViralVirus ReplicationRNA, MessengerRNA, Viral

Identifiers

PMID16611053
PMCPMC4863997
OpenAlexW2026115046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.